Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Impaired autophagy may contribute to alopecia areata.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

A 16-year-old boy had pernicious anemia, autoimmune hemolytic anemia, and later developed alopecia areata.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Type 1 diabetes patients often have other autoimmune diseases, which complicate their care.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Genetic discoveries are leading to new treatments for alopecia areata.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Atopic dermatitis increases the risk of some autoimmune diseases.

People with alopecia areata are more likely to have other immune-related conditions.

BST2 protein and certain T cells increase in early alopecia areata.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

DM and AA may share a common cause.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.